MonoBiologics

Executive Summary

MonoBiologics is an Irish company specializing in the manufacture and distribution of single-use bioprocessing equipment, including pumps, valves, and custom overmolded assemblies. Founded in 2015, the company serves the biopharmaceutical industry by providing solutions that streamline upstream and downstream manufacturing, cell therapy production, and fluid handling. By operating as both a direct manufacturer and a strategic distributor for other technology providers, MonoBiologics offers a comprehensive portfolio that addresses the growing demand for disposable components in bioprocessing. The company's focus on single-use technology positions it well within an industry increasingly adopting flexible, cost-effective, and contamination-free manufacturing processes. The global shift toward single-use bioprocessing equipment is driven by the need for faster changeovers, reduced cross-contamination risks, and lower capital investment. MonoBiologics, with its expertise in custom overmolded assemblies and partnerships with innovative technology providers, is poised to capture market share as biopharma manufacturers expand their single-use capabilities. While the company remains relatively small and privately held, its strategic location in Dublin and its niche focus on critical fluid handling components provide a solid foundation for growth. Key opportunities lie in expanding its product line to meet the needs of emerging cell and gene therapy modalities, as well as forging strategic partnerships with larger biopharma companies seeking reliable single-use supply chains.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation single-use pump or valve40% success
• Q1 2027Strategic distribution agreement with a major biopharma manufacturer30% success
• Q2 2027Expansion into the cell therapy market with custom assemblies35% success